Table 5 Overall and stratified analysis of mortality risk among patients with cancer between the patients with moderate/severe TBI and patients with mild TBI

Overall

1.01 (0.88–1.17)

0.8500

0.99(0.85–1.16)

0.9291

Sex

 Male

1.03 (0.87–1.21)

0.7436

1.00(0.84–1.19)

0.9746

 Female

1.01 (0.74–1.39)

0.9294

0.98(0.69–1.38)

0.9011

Age

 20–35

1.16 (0.68–1.96)

0.5935

1.23(0.67–2.26)

0.5025

 36–45

1.10 (0.80–1.51)

0.5612

1.01(0.71–1.44)

0.9554

 46–55

0.93 (0.73–1.19)

0.5732

0.90(0.70–1.17)

0.4398

 55–65

1.07 (0.84–1.36)

0.5800

1.07(0.82–1.40)

0.6206

Comorbidity

 HTN

1.16 (0.84–1.59)

0.3636

1.09(0.78–1.54)

0.6135

 DM

0.86 (0.57–1.29)

0.4663

0.79(0.51–1.21)

0.2777

 Hyperlipidemia

1.38 (0.79–2.39)

0.2573

1.03(0.57–1.86)

0.9204

 CAD

1.60 (0.82–3.11)

0.1661

1.52(0.78–2.94)

0.2184

 Renal disease

1.14 (0.37–3.53)

0.8237

1.72(0.54–5.46)

0.3602

 Stroke

1.00 (0.53–1.89)

0.9925

1.14(0.58–2.23)

0.7146